SBFLOX EYE/EAR DROPS Clinical Monograph & Batch COA
Certified DCGI Formulation Literature (PDF)
SBFLOX EYE/EAR DROPS
Ofloxacin IP 0.03%w/v + Benzalkonium IP 0.02%v/v
SBFLOX EYE/EAR DROPS is a broad-spectrum bactericidal antimicrobial agent exhibiting enhanced pharmacokinetic tissue penetration against susceptible gram-positive and gram-negative pathogens.
Clinical Pharmacology & Therapeutic Profile
Comprehensive therapeutic guidelines for medical practitioners and institutional procurement
Therapeutic Indications
Mechanism of Action (MOA)
Inhibits bacterial DNA gyrase (type II topoisomerase) and topoisomerase IV enzymes required for bacterial DNA replication, transcription, and repair.
Adult: One dose once or twice daily depending on infectious severity. Complete full course to prevent antimicrobial resistance.
Well tolerated under clinical supervision. Contraindicated in patients with hypersensitivity to active ingredients.
Store in a cool and dry place. Use within 1 month after opening container.
WHO-GMP Certified Purity
Manufactured in state-of-the-art HVAC controlled cleanrooms with 100% active ingredient bio-potency and analytical batch testing.
Alu-Alu Moisture Barrier
Superior barrier protection against tropical humidity, preventing physical degradation and guaranteeing 24-month stability.
Exclusive District Monopoly
Strict PCD franchise monopoly allocation ensuring zero price competition and complete territory protection for our partners.
Technical Product Specifications
Active Medical Composition
SBFLOX EYE/EAR DROPS features Ofloxacin IP 0.03%w/v + Benzalkonium IP 0.02%v/v prepared to high pharmaceutical purity standards.
*Disclaimer: Formulations are intended solely for distribution to licensed practitioners, hospitals, and pharmacies. Dosage must adhere to medical advice.
Customer & Clinical Reviews
Real feedback from registered physicians, stockists, PCD franchise partners, and verified buyers.
Based on 1 verified review
Tracked for therapeutic compliance for SBFLOX EYE/EAR DROPS
SBFLOX EYE/EAR DROPS has been tracked for therapeutic compliance across diverse adult cohorts, with attending physicians reporting swift symptom reduction across outpatients. The secondary carton board quality is heavy and durable, protecting contents from transport shock. Zero supply interruptions and consistent batch quality make this a standout pharmaceutical line.
Questions Regarding SBFLOX EYE/EAR DROPS
What is the therapeutic indication and composition of SBFLOX EYE/EAR DROPS?
SBFLOX EYE/EAR DROPS contains Ofloxacin IP 0.03%w/v + Benzalkonium IP 0.02%v/v indicated for Lower Respiratory Tract Infections as formulated by Sygnus Biotech.
What packaging presentations are available for SBFLOX EYE/EAR DROPS?
SBFLOX EYE/EAR DROPS is supplied in tamper-evident 5ml / 10ml Precision Dropper Bottle with Tamper Ring, engineered with barrier foil protection to ensure a 24 to 36 month shelf life.
Is monopoly PCD franchise territory available for SBFLOX EYE/EAR DROPS?
Yes, Sygnus Biotech grants exclusive district-wise monopoly marketing rights for SBFLOX EYE/EAR DROPS along with promotional visual aids, product cards, and marketing support.
What is the regulatory schedule and minimum order quantity (MOQ)?
SBFLOX EYE/EAR DROPS is categorized as Schedule H with an introductory PCD franchise MOQ of 100 units per batch.
Related Formulations in Drops
View all Drops →
OTINUS-S NASAL DROPS
Sodium Chloride 0.65% w/v + Benzalkonium Chloride Solution 0.02% v/v
